Hippo's Return to Profitability Meets Its First Real Quarterly Test Tomorrow—If the Model Holds
Hippo Holdings Inc. (HIPO) reports first quarter 2026 earnings before market open on April 30, 2026, with analysts expecting the insurtech company to post earnings of $0.06 per share. The central question: can Hippo sustain the dramatic turnaround that saw it beat estimates in three consecutive quarters after years of losses, or will the challenging Q1 comparison—when it lost $1.91 per share a year ago—reveal cracks in the recovery story?
Part 1: Earnings Preview
Hippo Holdings Inc. is a technology-native insurance platform specializing in homeowners insurance, leveraging smart home technology, data analytics, and digital tools to modernize coverage and risk management. The company has expanded beyond its core homeowners business to diversify risk across both personal and commercial lines through its carrier platform.
Hippo will report Q1 2026 results before market open on April 30, 2026. Analysts expect earnings of $0.06 per share on revenue of approximately $130.67 million, representing 18.46% revenue growth year-over-year. The company most recently reported Q4 2025 earnings of $0.41 per share, marking its third consecutive quarterly beat. The year-over-year comparison is dramatic: analysts forecast a swing from a $1.91 loss in Q1 2025 to profitability this quarter, representing 103.14% growth.
Three key themes define this earnings story:
Path to Sustainable Profitability: After posting three straight quarterly beats and achieving profitability in Q4 2025, investors are watching whether Hippo can maintain positive earnings despite the difficult Q1 2025 comparison. The company's ability to control expenses while growing premium volume will be critical, particularly as it scales its Data & Analytics function under newly appointed Chief Data Officer Robin Gordon.
Premium Growth and Retention Dynamics: Gross Written Premium (GWP) increased 40% to $288 million in Q4 2025, while Net Written Premium rose 23% to $97 million. Investors will scrutinize whether this momentum continues and how Premium Retention Rate trends, as these metrics directly impact the company's ability to achieve sustainable growth without excessive customer acquisition costs.
Risk Management and Loss Ratio Performance: With the company's technology-driven approach to underwriting and proactive risk detection through smart home integration, the Loss Ratio—which demonstrates claims efficiency—will be a key indicator of whether Hippo's insurtech model delivers superior risk management compared to traditional carriers, especially as it diversifies into commercial lines.
B. Riley Securities initiated coverage with a Buy rating and $38.00 price target in April 2026, citing the company's technology-driven competitive advantages. The firm's bullish stance reflects confidence in Hippo's ability to leverage advanced data and analytics to build a diversified, sustainable insurance platform. With the company appointing proven insurance industry leaders Laura Hay and Susan Holliday to its Board of Directors in September 2025, analyst commentary suggests institutional confidence in the strategic direction and governance oversight as Hippo scales its AI-powered Tinman platform.
Part 2: Historical Earnings Performance
Hippo has delivered a remarkable turnaround in earnings performance over the past year. The company beat analyst estimates in all four of the most recent quarters, with surprise percentages of +86.36% (Q4 2025), +276.00% (Q3 2025), +200.00% (Q2 2025), and a miss of -35.46% (Q1 2025). The pattern shows dramatic improvement: after missing estimates by $0.50 in Q1 2025 with a loss of $1.91 per share, Hippo swung to profitability and consistently exceeded expectations by wide margins.
The magnitude of the beats has been substantial. In Q2 2025, analysts expected a loss of $0.65 per share but Hippo delivered earnings of $0.65—a $1.30 positive surprise. Q3 2025 saw another massive beat with $0.44 in earnings versus expectations of a $0.25 loss, representing a $0.69 surprise. Even as estimates turned positive in Q4 2025, the company beat the $0.22 consensus with $0.41 in actual earnings.
The trend is unmistakably positive: Hippo has transformed from a money-losing insurtech struggling to meet expectations into a profitable company that consistently outperforms. The three consecutive quarters of substantial beats suggest the company has achieved operational inflection, though the upcoming Q1 2026 report will test whether this momentum can be sustained against easier year-ago comparisons.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Mar 2025 | $-1.41 | $-1.91 | -35.46% | Miss |
| Jun 2025 | $-0.65 | $0.65 | +200.00% | Beat |
| Sep 2025 | $-0.25 | $0.44 | +276.00% | Beat |
| Dec 2025 | $0.22 | $0.41 | +86.36% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Hippo typically reports earnings before market open, meaning Day 0 represents the first full trading session where the market reacts to results, while Day +1 captures follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-02-24 | +$1.02 (+3.67%) | $1.23 (4.42%) | -$1.41 (-4.89%) | $4.08 (14.16%) |
| 2025-11-05 | +$1.96 (+5.46%) | $4.33 (12.05%) | -$3.25 (-8.59%) | $3.84 (10.15%) |
| 2025-08-06 | +$3.88 (+14.03%) | $4.51 (16.31%) | -$1.70 (-5.39%) | $3.05 (9.67%) |
| 2025-05-07 | +$0.44 (+1.83%) | $0.79 (3.31%) | -$3.89 (-15.90%) | $3.08 (12.59%) |
| 2025-03-05 | +$0.38 (+1.30%) | $1.03 (3.53%) | +$0.69 (+2.33%) | $5.44 (18.38%) |
| 2024-11-08 | +$4.53 (+19.18%) | $5.21 (22.06%) | +$1.51 (+5.36%) | $1.59 (5.65%) |
| 2024-08-08 | +$4.33 (+27.81%) | $2.80 (17.98%) | -$1.45 (-7.29%) | $2.33 (11.71%) |
| 2024-05-02 | -$3.00 (-13.65%) | $4.02 (18.30%) | -$0.71 (-3.74%) | $1.57 (8.25%) |
| Avg Abs Move | 10.87% | 12.24% | 6.69% | 11.32% |
Hippo's post-earnings price behavior has been highly volatile, with an average absolute Day 0 move of 10.87% and Day +1 move of 6.69%. The direction has been mixed: recent reports show Day 0 gains of 3.67% (Feb 2026), 5.46% (Nov 2025), and 14.03% (Aug 2025), but these were often followed by Day +1 reversals, including declines of 4.89%, 8.59%, and 5.39% respectively. The most dramatic reaction came in November 2024 when the stock surged 19.18% on Day 0 and added another 5.36% on Day +1, while August 2024 saw a 27.81% Day 0 spike followed by a 7.29% Day +1 decline.
The average Day 0 range of 12.24% and Day +1 range of 11.32% indicate substantial intraday volatility regardless of direction. Investors should expect significant price swings: even when the initial reaction is positive, follow-through has been inconsistent, with several instances of sharp reversals in the session following the report. The pattern suggests the market is still calibrating its view of Hippo's business model and profitability trajectory, leading to outsized moves as results either confirm or challenge the evolving narrative.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 05/15/26 (DTE 16) |
| Expected Move | $1.15 (4.07%) |
| Expected Range | $27.07 to $29.37 |
| Implied Volatility | 86.01% |
The options market is pricing a 4.07% expected move for the May 15, 2026 expiration, significantly below Hippo's historical average Day 0 move of 10.87% and Day +1 move of 6.69%. This suggests options traders are anticipating a more muted reaction than the stock has historically delivered around earnings, potentially reflecting increased confidence in the company's stabilized profitability or reduced uncertainty compared to prior quarters when the turnaround story was less established.
Part 3: What Analysts Are Saying
Analyst sentiment on Hippo is cautiously optimistic, with a consensus rating of 4.00 (Buy) and an average price target of $37.75, implying 33.8% upside from the current price of $28.22. The rating breakdown shows 3 Strong Buys, 0 Moderate Buys, 3 Holds, 0 Moderate Sells, and 0 Strong Sells among the 6 analysts covering the stock.
Sentiment has improved over the past month, with Strong Buy ratings increasing from 2 to 3 while the Hold count remained steady at 3. The average recommendation strengthened from 3.80 to 4.00, reflecting growing analyst confidence in the company's trajectory. The price target range spans from a low of $30.00 to a high of $45.00, with the high estimate suggesting potential upside of nearly 60%.
The improved sentiment appears driven by Hippo's consistent earnings beats and the company's successful pivot to profitability. B. Riley Securities' April 2026 initiation with a Buy rating and $38.00 target underscores the view that Hippo's technology-driven platform and diversification strategy position it for sustainable growth. However, the presence of three Hold ratings indicates some analysts remain cautious, likely awaiting further evidence that the profitability turnaround can be sustained across different market conditions and as the company scales its commercial lines business.
Part 4: Technical Picture
The Barchart Technical Opinion shows a 40% Sell signal, representing a significant improvement from the 56% Sell reading last week and the 100% Sell signal a month ago. This weakening bearish stance suggests technical pressure is easing as the stock consolidates ahead of earnings.
Timeframe Analysis:
- Short-term (Hold): Neutral signal indicates near-term momentum has stabilized after recent weakness
- Medium-term (50% Sell): Moderate sell signal suggests the intermediate-term trend remains under pressure
- Long-term (100% Sell): Strong sell signal reflects persistent weakness in the longer-term trend structure
Trend Characteristics: The trend is characterized as Soft and Weakening, indicating diminishing downside pressure but not yet a confirmed reversal, creating an uncertain technical backdrop heading into the earnings release.
The stock is trading at $28.22, positioned below its 5-day ($28.58), 10-day ($28.57), 100-day ($28.69), and 200-day ($30.83) moving averages, but above its 20-day ($27.41) and 50-day ($27.04) moving averages. This mixed picture—with the stock below longer-term trend indicators but holding above intermediate support—suggests the technical setup is neither strongly supportive nor decisively bearish.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $28.58 | 50-Day MA | $27.04 |
| 10-Day MA | $28.57 | 100-Day MA | $28.69 |
| 20-Day MA | $27.41 | 200-Day MA | $30.83 |
Key technical levels to watch include the 50-day moving average at $27.04, which has provided support, and the 100-day average at $28.69, which represents immediate overhead resistance. The stock's position below its 200-day moving average of $30.83 indicates it remains in a longer-term downtrend despite recent stabilization. The overall technical setup is cautiously neutral: while the easing of sell signals and support above the 50-day average provide some stability, the stock's failure to reclaim longer-term moving averages and the persistent medium- and long-term sell signals suggest limited technical momentum heading into earnings. Investors should be prepared for the historical volatility pattern to reassert itself, particularly given the stock's tendency to experience double-digit percentage moves around earnings releases.